Showing results (1-10 of 244) with videos related to
Sort By:
Pageof 25
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|September 26, 2018
Polymyalgia rheumatica due to pembrolizumab therapyAndrew Iskandar, Andrew Hwang, Constantin A DasanuJournal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|November 30, 2018
Severe warm-antibody autoimmune hemolytic anemia due to multicentric Castleman disease: Responding to rituximabAndrew Iskandar, Andrew Hwang, Constantin A DasanuJournal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|December 22, 2018
Successful re-introduction of alectinib after inducing interstitial lung disease in a patient with lung cancerAndrew Hwang, Andrew Iskandar, Constantin A DasanuJournal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|August 9, 2018
Stevens-Johnson syndrome manifesting late in the course of pembrolizumab therapyAndrew Hwang, Andrew Iskandar, Constantin A DasanuJournal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|March 3, 2018
Cystic acne due to imatinib therapy for chronic myelocytic leukemiaAndrew Hwang, Andrew Iskandar, Michael Del Rosario, et al.BMJ Case Reports|August 3, 2018
EGFR inhibitor-induced cut-like skin lesions of the fingersAndrew S Iskandar, Andrew Hwang, Constantin A DasanuJournal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|November 26, 2020
Cures with B-Raf inhibitors as single agents in metastatic B-Raf mutated melanoma: Curb your enthusiasm?Constantin A DasanuJournal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|July 18, 2012
Length of adjuvant imatinib therapy in GIST: weighing benefits, side effects and costsConstantin A DasanuExpert Opinion on Pharmacotherapy|April 14, 2011
Newer developments in adult T-cell leukemia/lymphoma therapeuticsConstantin A DasanuJournal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|January 21, 2011
Targeting macrophages in classical Hodgkin's lymphoma may seem rational, but is it safe?Constantin A DasanuPageof 25